Dosing cohort 3 of the Phase 1 trial of LNCB74 (B7-H4 ADC) in multiple cancers and plan to initiate backfill…
– Topline histology data from ENLIGHTEN-Fibrosis and ENLIGHTEN-Cirrhosis Phase 3 trials are expected in 1H 2027 and in 2028, respectively;…
Railroad Delivers Q1 Diluted EPS of C$1.85, an 8% increaseMONTREAL, May 01, 2025 (GLOBE NEWSWIRE) -- CN (TSX: CNR) (NYSE:…
SUNNYVALE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- GSI Technology, Inc. (NASDAQ: GSIT) today reported financial results for its fourth…
– Acquired one property for $79.8 million –– Signed comparable leases on 109,000 square feet for growth of 37.2% ––…
SAN FRANCISCO, May 01, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on…
Q3 2025 Recurring & Other Revenue of $421.1 million, up 15% year-over-yearQ3 2025 Total Revenue of $454.5 million, up 13%…
1,100 bed health system selects eValutor’s pre-bill code audit technology to improve coding accuracyATLANTA, May 01, 2025 (GLOBE NEWSWIRE) --…
SEATTLE, May 01, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that…
$3.7 billion of minimum contracted revenues from 82 vessel pro-forma fleet 16-vessel shuttle tanker fleet making TEN on the largest…
This website uses cookies.
